Delivery Order SPE2DR25D1017-SPE2DR26F9BLA
- Not listed
- The Defense Logistics Agency awarded a $1,627.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CREXONT ER 87.5 MG-350 MG capsules (120-count supply) on December 5, 2025, with completion scheduled for December 8, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a $5,851.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for CREXONT ER 87.5 MG-350 MG capsules (120-count supply). This non-set-aside competitive award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $4,030.34 to AmerisourceBergen Drug Corp for the supply of CREXONT ER 87.5 MG-350 MG capsules (120 count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, issued under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $6,672.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on September 5, 2025, with completion targeted for September 8, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Crexont ER 87.5 mg-350 mg capsules (120 count) with a ceiling value of $3,224.67. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,272.44 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Crexont ER 70 mg-280 mg capsules (120-count). This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,231.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for CREXONT ER 70 mg-280 mg capsules (120-count supply). This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 28, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,684.31 delivery order to AmerisourceBergen Drug Corp for Crexont ER 280 mg capsules (120 count) on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999...
- The Defense Logistics Agency awarded a $1,644.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on September 26, 2025, with completion expected by September 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The prime contract serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,966.32 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 mg–210 mg capsules (120 count). The contract, executed on October 27, 2025, with an ultimate completion date of October 28, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BLADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,303.83 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 MG-350 MG capsules (120 count) on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the contractor's critical role as a pharmaceutical supplier to the federal government's medical supply chain. This delivery order derives from AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract awards demonstrate significant capability in fulfilling diverse pharmaceutical needs across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 12/14/25 |